4.8 Article

High-Dose Ursodeoxycholic Acid Therapy for Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Trial

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Betaine for Nonalcoholic Fatty Liver Disease: Results of a Randomized Placebo-Controlled Trial

Manal F. Abdelmalek et al.

HEPATOLOGY (2009)

Review Gastroenterology & Hepatology

Primary Biliary Cirrhosis

Keith D. Lindor et al.

HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis

Glen Lutchman et al.

HEPATOLOGY (2007)

Article Medicine, General & Internal

Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes

Steven E. Nissen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Gastroenterology & Hepatology

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis

Jean-Francois Dufour et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)

Article Medicine, General & Internal

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

Renata Belfort et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

JP Despres et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Gastroenterology & Hepatology

Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis

T Fukusato et al.

HEPATOLOGY RESEARCH (2005)

Article Gastroenterology & Hepatology

Sampling variability of liver biopsy in nonalcoholic fatty liver disease

V Ratziu et al.

GASTROENTEROLOGY (2005)

Article Gastroenterology & Hepatology

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

DE Kleiner et al.

HEPATOLOGY (2005)

Article Medicine, Research & Experimental

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

D Osei-Hyiaman et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Article Gastroenterology & Hepatology

Immunomodulating and anti-apoptotic action of ursodeoxycholic acid: where are we and where should we go?

S Bellentani

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)

Article Endocrinology & Metabolism

Plasma adiponectin is decreased in nonalcoholic fatty liver disease

C Pagano et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)

Article Gastroenterology & Hepatology

4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells

E Zamara et al.

JOURNAL OF HEPATOLOGY (2004)

Article Gastroenterology & Hepatology

A pilot study of ploglitazone treatment for nonalcoholic steatohepatitis

K Promrat et al.

HEPATOLOGY (2004)

Article Gastroenterology & Hepatology

Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study

S Merat et al.

JOURNAL OF HEPATOLOGY (2003)

Article Gastroenterology & Hepatology

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

G Marchesini et al.

HEPATOLOGY (2003)

Article Gastroenterology & Hepatology

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis

M Kiyici et al.

CANADIAN JOURNAL OF GASTROENTEROLOGY (2003)

Article Gastroenterology & Hepatology

Tumor necrosis factor-α and transforming growth factor-β reflect severity of liver damage in primary biliary cirrhosis

M Neuman et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)

Article Gastroenterology & Hepatology

Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities

AJ Sanyal et al.

GASTROENTEROLOGY (2001)